" Resverlogix (TSX:RVX) in discussions for COVID-19 clinical studies in Morocco
Resverlogix (RVX) is in discussions to launch Phase 2 COVID-19 clinical studies with Apabetalone in Morocco.
" Advanced Proteome Therapeutics (TSXV:APC) provides update on COVID program
Advanced Proteome Therapeutics Corporation (APC) is dedicating additional resources to its SARS-CoV-2 protease inhibitor program.
" Teck (TSX:TECK.A) donates $500,000 to support global access to COVID-19 vaccines
Teck Resources Limited (TECK.A) has announced a $500,000 donation to UNICEF Canada in support of the COVID-19 Vaccine Global Access Facility (COVAX).
" FluroTech (TSXV:TEST) announces closing of amalgamation
FluroTech (TEST), subsidiaries Subco and FluroTest Diagnostic Systems have completed the previously announced three-cornered amalgamation.
" Therma Bright (TSXV: THRM) announces EU-CE approval for AcuVid COVID-19 rapid antigen saliva test and secures conditional sale of 100,000 CE-only AcuVid test kits
Therma Bright Inc. (THRM) has received CE approval certification for its AcuVid™ COVID-19 rapid antigen saliva test.